186 related articles for article (PubMed ID: 26536412)
1. Eliminating Extravasation Events: A Multidisciplinary Approach.
Coyle CE; Griffie J; Czaplewski LM
J Infus Nurs; 2015; 38 Suppl 6():S43-50. PubMed ID: 26536412
[TBL] [Abstract][Full Text] [Related]
2. Eliminating extravasation events: a multidisciplinary approach.
Coyle CE; Griffie J; Czaplewski LM
J Infus Nurs; 2014; 37(3):157-64. PubMed ID: 24694509
[TBL] [Abstract][Full Text] [Related]
3. Preventing and managing vesicant chemotherapy extravasations.
Schulmeister L
J Support Oncol; 2010; 8(5):212-5. PubMed ID: 21086879
[TBL] [Abstract][Full Text] [Related]
4. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
Sauerland C; Engelking C; Wickham R; Corbi D
Oncol Nurs Forum; 2006 Nov; 33(6):1134-41. PubMed ID: 17149396
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy Extravasation: Establishing a National Benchmark for Incidence Among Cancer Centers.
Jackson-Rose J; Del Monte J; Groman A; Dial LS; Atwell L; Graham J; O'Neil Semler R; O'Sullivan M; Truini-Pittman L; Cunningham TA; Roman-Fischetti L; Costantinou E; Rimkus C; Banavage AJ; Dietz B; Colussi CJ; Catania K; Wasko M; Schreffler KA; West C; Siefert ML; Rice RD
Clin J Oncol Nurs; 2017 Aug; 21(4):438-445. PubMed ID: 28738039
[TBL] [Abstract][Full Text] [Related]
6. A flow sheet for follow-up after chemotherapy extravasation.
Davis ME; DeSantis D; Klemm K
Oncol Nurs Forum; 1995 Jul; 22(6):979-83. PubMed ID: 7567616
[TBL] [Abstract][Full Text] [Related]
7. Vesicant extravasation part II: Evidence-based management and continuing controversies.
Wickham R; Engelking C; Sauerland C; Corbi D
Oncol Nurs Forum; 2006 Nov; 33(6):1143-50. PubMed ID: 17149397
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological management of anticancer agent extravasation: A single institutional guideline.
Kimmel J; Fleming P; Cuellar S; Anderson J; Haaf CM
J Oncol Pharm Pract; 2018 Mar; 24(2):129-138. PubMed ID: 29284352
[TBL] [Abstract][Full Text] [Related]
9. Managing vesicant extravasations.
Schulmeister L
Oncologist; 2008 Mar; 13(3):284-8. PubMed ID: 18378538
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy extravasation from implanted ports.
Schulmeister L; Camp-Sorrell D
Oncol Nurs Forum; 2000 Apr; 27(3):531-8; quiz 539-40. PubMed ID: 10785905
[TBL] [Abstract][Full Text] [Related]
11. Risk management of extravasation of cytostatic drugs at the Adult Chemotherapy Outpatient Clinic of a university hospital.
Adami NP; de Gutiérrez MG; da Fonseca SM; de Almeida EP
J Clin Nurs; 2005 Aug; 14(7):876-82. PubMed ID: 16000102
[TBL] [Abstract][Full Text] [Related]
12. European Oncology Nursing Society extravasation guidelines.
Wengström Y; Margulies A;
Eur J Oncol Nurs; 2008 Sep; 12(4):357-61. PubMed ID: 18765210
[TBL] [Abstract][Full Text] [Related]
13. Extravasation management.
Schulmeister L
Semin Oncol Nurs; 2007 Aug; 23(3):184-90. PubMed ID: 17693345
[TBL] [Abstract][Full Text] [Related]
14. Developing extravasation protocols and monitoring outcomes.
Camp-Sorrell D
J Intraven Nurs; 1998; 21(4):232-9. PubMed ID: 9866539
[TBL] [Abstract][Full Text] [Related]
15. Vesicant extravasation: myths and realities.
Boyle DM; Engelking C
Oncol Nurs Forum; 1995; 22(1):57-67. PubMed ID: 7708525
[TBL] [Abstract][Full Text] [Related]
16. Dexrazoxane: a management option for anthracycline extravasations.
Vidall C; Roe H; Dougherty L; Harrold K
Br J Nurs; 2013 Sep 12-25; 22(17):S6 -12. PubMed ID: 24067273
[TBL] [Abstract][Full Text] [Related]
17. Reader looking for guidelines/policies on continuous infusion vesicants for assessments.
Parran L
Oncol Nurs Forum; 2000 Sep; 27(8):1201-2. PubMed ID: 11013900
[No Abstract] [Full Text] [Related]
18. [Extravasation of chemotherapeutic agents: prevention and therapy].
Jordan K; Grothe W; Schmoll HJ
Dtsch Med Wochenschr; 2005 Jan; 130(1-2):33-7. PubMed ID: 15619172
[TBL] [Abstract][Full Text] [Related]
19. Antidotes to vesicant chemotherapy extravasations.
Dorr RT
Blood Rev; 1990 Mar; 4(1):41-60. PubMed ID: 2182147
[TBL] [Abstract][Full Text] [Related]
20. Port-a-Cath extravasation of vesicant cytotoxics: surgical options for a rare complication of cancer chemotherapy.
Haslik W; Hacker S; Felberbauer FX; Thallinger C; Bartsch R; Kornauth C; Deutschmann C; Mader RM
Eur J Surg Oncol; 2015 Mar; 41(3):378-85. PubMed ID: 25515823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
